Delivery Order SPE2DB22D3501-SPE2DB25FWM05
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Rectiv 0.4% Ointment in 30-gram units. This is a firm fixed-price delivery order with a ceiling value of $1,927.00, with an ultimate completion date of June 2, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania served as the place of performance. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Rectiv 0.4% Ointment in 30-gram quantities, with a ceiling value of $2,518.06 and an ultimate completion date of September 5, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical...
- The Defense Logistics Agency awarded a $4,465.84 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Rectiv 0.4% Ointment in 30-gram units, with completion scheduled for August 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Rectiv 0.4% Ointment in 30-gram units. This firm fixed-price delivery order, valued at $2,833.45, was competitively awarded without a set-aside designation and carries an ultimate completion date of September 17, 2025. The place of performance is located at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,219.76 to AmerisourceBergen Drug Corp for Rectiv 0.4% Ointment in a 30-gram quantity. The contract was competitively awarded without a set-aside designation and utilizes firm fixed pricing. This delivery order was completed on April 23, 2025, one day after the award date of April 22, 2025. The product will be performed and sourced from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Rectiv 0.4% Ointment in 30-gram units, with a firm fixed price ceiling value of $1,570.88 and an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 15, 2025, for Rectiv 0.4% Ointment in 30-gram quantities, with a ceiling value of $3,515.21. This firm fixed-price delivery order, which will be completed by May 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will occur at...
- The Defense Logistics Agency awarded a delivery order valued at $2,207.91 to AmerisourceBergen Drug Corp on September 4, 2025, for Rectiv 0.4% Ointment in 30-gram units. This is a firm fixed price delivery order with no set-aside designation, with an ultimate completion date of September 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,628.24 to AmerisourceBergen Drug Corp for RECTIV 0.4% Ointment (30 grams) on August 4, 2025, with an ultimate completion date of August 5, 2025. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $4,655.93 to AmerisourceBergen Drug Corp for RECTIV 0.4% Ointment in 30-gram units. This competitive delivery order, issued on September 15, 2025, with completion expected by September 16, 2025, represents a firm fixed-price procurement with no set-aside designation. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWM05Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Rectiv 0.4% Ointment in 30-gram units. This is a firm fixed price contract with a ceiling value of $1,668.99 and an ultimate completion date of July 21, 2025. The contract was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables comprehensive pharmaceutical supply to military and federal healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates capability across diverse pharmaceutical categories including specialty medications, vaccines, generic drugs, and medical devices. This specific delivery order for topical ointment represents one of numerous individual transactions executed under the broader DLA pharmaceutical prime vendor agreement that facilitates flexible procurement of essential medical supplies for military personnel and federal healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/18/25 |